| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30979d9e827a8f605b4b586951390cde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc19d8d6ba9ad5c1fa5770341472b56 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate |
1995-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e636086370919d319dafc772a34c9c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d985f90c36e271043e84e0521946645c |
| publicationDate |
2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6391588-B1 |
| titleOfInvention |
Nucleic acid molecules encoding truncated insulin-like growth factor binding-5 proteins |
| abstract |
Purified compounds comprising truncated insulin-like growth factor binding protein (IGFBP) capable of binding to an antibody specific for the compound or to an insulin-like growth factor wherein the truncated IGFBP has a decreased affinity for insulin-like growth factors (IGFs) are described. Recombinant DNA molecules encoding the truncated IGFBPs are also described along with recombinant microorganisms and cell lines containing the DNA molecules and methods for producing the truncated IGFBPs using recombinant hosts containing the relevant DNA molecules. Methods for stimulating mitogenic activity and also for treating a bone disorder in mammals are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008241960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006073514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7858091-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008199886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7109030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7348154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7351545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005148035-A1 |
| priorityDate |
1992-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |